Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast

Tumor Biology

Volumn 25, Issue 5-6, 2004, Pages 290-295

  Yazhou, Cui ^a   Wenlv, Shen ^a   Weidong, Zhang ^b   Licun, Wu ^b  

^a THE SECOND AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Breast; Ductal carcinoma; Myofibroblasts; Smooth muscle actin

Indexed keywords

CD34 ANTIGEN;

ARTICLE; BREAST; BREAST CARCINOMA; BREAST FIBROADENOMA; BREAST HYPERPLASIA; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MICROVASCULATURE; MYOFIBROBLAST; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

EID: 11444259166     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081394     Document Type: Article

References (18)

1. Walker RA: The complexities of breast cancer desmoplasia. Breast Cancer Res 2001;3:143-145.
2. Valenti MT, Sartore S, Azzarello G, Balducci E, Amadio M, Sandri M, Pappagallo GL, Tacchetti G, Bari M, Manconi R, D'Andrea MR, Silvestri B, Vinante O: Human fibroblasts from normal and malignant breast tissue grown in vitro show a distinct senescence profile and telomerase activity. Histochem J 2002;34:403-410.
3. Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R: CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch 2002;440:298-303.
4. Vrana JA, Stang MT, Grande JP, Getz MJ: Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: Paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res 1996;56:5063-5070.
5. Offersen BV, Nielsen BS, Hoyer-Hansen G, Rank F, Hamilton-Dutoit S, Overgaard J, Andreasen PA: The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas. Am J Pathol 2003;163:1887-1899.
6. Giani C, Cullen KJ, Campani D, Rasmussen A: IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: An in situ hybridization and immunohistochemistry study. Breast Cancer Res Treat 1996;41:43-50.
7. Seslar S, Nakamura T, Byers S: Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: A role for transforming growth factor-beta activation. Endocrinology 1995;136:1945-1953.
8. Singer CF, Hudelist G, Galid A, Kubista E: Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment. Drugs Today (Barc) 2003;39:917-926.
9. Silverman JS, Tamsen A: Observations on the role of FXIIIa+ dendritic mammary stromal cells in myofibroblastic stromal remodeling and angiogenesis in mammary carcinoma. Cell Vis 1998;5:77-79.
10. Barth PJ, Ramaswamy A, Moll R: CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch 2002;441:564-568.
11. Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Hiroi M: Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J Clin Pathol 2000;53:626-629.
12. Barth PJ, Schenck zu Schweinsberg T, Ramaswamy A, Moll R: CD34+ fibrocytes, alphasmooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 2004;444:231-234.
13. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ: Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: Evidence for paracrine function. Cancer Res 1995;55:2448-2454.
14. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions. Cancer Res 1997;57:3305-3313.
15. Sieuwerts AM, Klijn JG, Henzen-Logmand SC, Bouwman I, Van Roozendaal KE, Peters HA, Setyono-Han B, Foekens JA: Urokinasetype-plasminogen-activator (uPA) production by human breast (myo)fibroblasts in vitro: Influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells. Int J Cancer 1998;76:829-835.
16. Singer CF, Kubista E, Garmroudi F, Cullen KJ: Local feedback mechanisms in human breast cancer. Breast Cancer Res Treat 2000;63:95-104.
17. Hasebe T, Sasaki S, Imoto S, Ochiai A: Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast. Am J Pathol 2000;156:1701-1710.
18. Hlatky L, Tsionou C, Hahnfeldt P, Coleman CN: Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 1994;54:6083-6086.